Zimmer Biomet Holdings (XSWX:ZBH) Cyclically Adjusted FCF per Share: CHF5.88 (As of Mar. 2026)


XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
72 GF Score
Price CHF71.00
GF Value CHF99.84
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Cyclically Adjusted FCF per Share?

Zimmer Biomet Holdings XSWX:ZBH +2.16% 72 Cyclically Adjusted FCF per Share is CHF5.88 as of Mar. 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 72/100 and a GF Value™ of CHF99.84. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zimmer Biomet Holdings's adjusted free cash flow per share for the three months ended in Mar. 2026 was CHF1.142. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is CHF5.88 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zimmer Biomet Holdings's average Cyclically Adjusted FCF Growth Rate was 4.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 2.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 3.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Zimmer Biomet Holdings was 11.70% per year. The lowest was 1.90% per year. And the median was 4.60% per year.

As of today (2026-07-07), Zimmer Biomet Holdings's current stock price is CHF71.00. Zimmer Biomet Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was CHF5.88. Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF of today is 12.07.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zimmer Biomet Holdings was 26.80. The lowest was 10.83. And the median was 18.74.


Zimmer Biomet Holdings  (XSWX:ZBH) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=71.00/5.88
=12.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zimmer Biomet Holdings was 26.80. The lowest was 10.83. And the median was 18.74.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zimmer Biomet Holdings Cyclically Adjusted FCF per Share Related Terms


Zimmer Biomet Holdings Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Cyclically Adjusted FCF per Share Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.91 5.86 5.64 7.29 6.78

Zimmer Biomet Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 8.80 5.53 6.78 5.88

XSWX:ZBH vs STE, PEN, GMED: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF falls into.


XSWX:ZBH
72GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zimmer Biomet Holdings Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zimmer Biomet Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.142/330.2130*330.2130
=1.142

Current CPI (Mar. 2026) = 330.2130.

Zimmer Biomet Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 1.622 241.018 2.222
201609 1.421 241.428 1.944
201612 2.880 241.432 3.939
201703 1.145 243.801 1.551
201706 1.948 244.955 2.626
201709 2.017 246.819 2.698
201712 1.726 246.524 2.312
201803 2.149 249.554 2.844
201806 1.772 251.989 2.322
201809 1.992 252.439 2.606
201812 1.613 251.233 2.120
201903 1.195 254.202 1.552
201906 0.213 256.143 0.275
201909 2.485 256.759 3.196
201912 1.756 256.974 2.256
202003 1.908 258.115 2.441
202006 -0.330 257.797 -0.423
202009 1.539 260.280 1.953
202012 1.725 260.474 2.187
202103 0.976 264.877 1.217
202106 1.850 271.696 2.248
202109 1.705 274.310 2.052
202112 1.351 278.802 1.600
202203 0.888 287.504 1.020
202206 1.438 296.311 1.603
202209 1.868 296.808 2.078
202212 0.668 296.797 0.743
202303 1.086 301.836 1.188
202306 0.851 305.109 0.921
202309 0.948 307.789 1.017
202312 2.159 306.746 2.324
202403 0.559 312.332 0.591
202406 1.138 314.175 1.196
202409 1.373 315.301 1.438
202412 1.879 315.605 1.966
202503 1.486 319.799 1.534
202506 1.222 322.561 1.251
202509 1.416 324.800 1.440
202512 1.743 324.054 1.776
202603 1.142 330.213 1.142

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of CHF5.88 mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Cyclically Adjusted FCF per Share of CHF5.88 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' Cyclically Adjusted FCF per Share too high?
Zimmer Biomet Holdings' current Cyclically Adjusted FCF per Share is CHF5.88. Overall, Zimmer Biomet Holdings has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Cyclically Adjusted FCF per Share compare to STE and PEN?
Zimmer Biomet Holdings' Cyclically Adjusted FCF per Share of CHF5.88 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Cyclically Adjusted FCF per Share is CHF5.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (XSWX:ZBH) has a current Cyclically Adjusted FCF per Share of CHF5.88. The stock's GF Value™ is CHF99.84, compared to a current price of CHF71.00 — trading 28.9% below its estimated fair value. The current Cyclically Adjusted FCF per Share is CHF5.88. Zimmer Biomet Holdings' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Cyclically Adjusted FCF per Share is CHF5.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF71.00 is trading 28.9% below its estimated GF Value™ of CHF99.84.

Key valuation signals for XSWX:ZBH:

  • Cyclically Adjusted FCF per Share: CHF5.88
  • GF Value™: CHF99.84 vs. price of CHF71.00 (28.9% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
72GF Score

Get the complete analysis for XSWX:ZBH

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF71.00
Price
CHF99.84
GF Value